http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106668537-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_459f485a5ec6c3a54cae33be63b1f746 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate | 2015-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6342d2ab932a750615dee22442456c30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2048c5336140e87990f4618e21363053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44c91f468ba6cf2f05d859538d462f1e |
| publicationDate | 2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106668537-A |
| titleOfInvention | Hui nationality traditional Chinese medicine radix sophorae tonkinensis, lentinula edodes and pseudobulbus cremastrae seu pleiones esophagus cancer restraining oral liquid and preparation method thereof |
| abstract | The invention discloses a formula of a Hui nationality traditional Chinese medicine radix sophorae tonkinensis, lentinula edodes and pseudobulbus cremastrae seu pleiones esophagus cancer restraining oral liquid and a preparation method thereof. The oral liquid belongs to a green high-tech Chinese herbal medicine for treating an esophagus cancer, belongs to a traditional Chinese medicine oral liquid formed by mixing Chinese herbal medicines, such as radix sophorae tonkinensis, lentinus edodes, pseudobulbus cremastrae seu pleiones and sal ammoniacus according to a certain ratio, boiling with water, extracting and concentrating, mainly treats the esophagus cancer, also treats digestive system cancers, such as a pharyngolaryngeal cancer, a stomach cancer and a colorectal cancer, and has the characteristics that drug tastes and doses are moderate, selected drugs are proved, through modern medical pharmacological experiments, to be capable of treating cancers, and through adoption of the oral liquid, the physical function is fundamentally improved at low cost, cell canceration is prevented and controlled, and health is regained. |
| priorityDate | 2015-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.